SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst intense community debate after pulling its compounded weight-loss pill following regulatory pressure, coinciding with significant buzz around its Super Bowl commercial. Investors are sharply divided, with bulls anticipating a rebound from reduced legal risk, while bears predict further downside due to perceived management missteps and a hit to the company's growth narrative.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to record Super Bowl betting volume and its ongoing expansion into prediction markets, sparking community debate over immediate revenue opportunities versus competitive pressures and the evolving regulatory landscape surrounding these platforms.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively discussed as political and cultural commentary intensifies around the Super Bowl halftime show, prompting widespread debate on "anti-American" themes and "woke" culture, while concurrently fueling speculation about Donald Trump's past associations, particularly regarding the Epstein files.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as community sentiment soars after Hims & Hers pulled its compounded weight-loss pill following regulatory scrutiny and NVO's legal threats, reinforcing the competitive advantage of approved GLP-1 therapies. Many anticipate a significant boost to NVO's market share for its Wegovy pill, with additional buzz surrounding its Super Bowl commercial amplifying discussions on potential sales impact.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending ahead of its Q4 earnings report on Monday, with the community highly anticipating a strong beat and solid 2026 guidance for its AI-powered credit platform. Investors are keenly watching for a potential short squeeze, believing the stock remains significantly undervalued despite recent market volatility and fresh funding agreements.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid a broader software sector sell-off driven by fears that AI will disrupt established business models, despite the company securing a significant $5.6 billion U.S. Army contract and actively integrating AI through initiatives like Agentforce. The community is sharply divided between those viewing the current dip as a generational buying opportunity and those concerned about a lasting valuation reset for enterprise SaaS.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after announcing a $250 million financing amendment extending its capital runway through 2028, triggering widespread community speculation for a potential short squeeze, though some caution against its history of volatility and concerns over dilution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is garnering significant buzz following its impactful Super Bowl commercial featuring Christina Applegate, which the community expects to drive Briumvi's patient adoption and sales amidst positive preliminary financial results and ongoing discussions about its strong market position and buyout potential.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is seeing intense community discussion amid technical glitches preventing users from closing Super Bowl prediction market contracts, all while the stock's price remains closely tied to cryptocurrency volatility ahead of its earnings report.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following its announcement of an expected first-ever adjusted quarterly operating profit and reaching 100 million battery swaps. This news has sparked a fervent debate among investors regarding its true valuation, with bulls anticipating a significant re-rating while bears caution against a temporary rally amid ongoing dilution concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy

Senseonics (SENS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval

Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.

Senseonics (NYSE:SENS) Stock Price Up 3.9% - Time to Buy?

Senseonics (NYSE:SENS) Shares Up 3.9% - Should You Buy...

SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

<ul class="summary-bullets"><li>Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.&nbsp;</li><li>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, the company said.</li><li>The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management.</li></ul>Shares of Senseonics Holdings, Inc. (SENS) closed over 8% higher on Thursday after the company announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.Senseonics said that alongside Sequel, it has launched the integration of the products with the first patients having received a Sequel twiist AID system paired with the Eversense 365 CGM.Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.The company’s shares were up 0.14% in after-market hours at the time of writing.<h2 class="st-heading-2">World’s First AID Integration</h2>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, representing a major milestone in long-term diabetes management by reducing the need for regular sensor changes and re-pairing, while maintaining exceptional accuracy, the company said.“Patients and providers want reliable, long-term automated glucose readings and we’ve taken a major step forward in simplifying and personalizing diabetes management by integrating Eversense 365’s One Year CGM system with the twiist AID system for patients that require insulin,” Goodnow said.Meanwhile, Alan Lotvin, CEO of Sequel MedTech said that diabetes management is deeply personal, and no single approach works for everyone. “Our focus on personalization means Sequel is committed to creating choice for people living with diabetes; integration with the Eversense CGM is an important step in this journey, enabling more people to experience the precision and confidence that twiist AID system brings to diabetes management,” he added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_at_3_22_54_AM_png_4f2919b8d5.webp" alt="On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes." width="1303" height="157"></figure><a href="https://stocktwits.com/symbol/SENS">Shares of SENS</a> have lost over 17% of their value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

An Asian teenager with type 1 diabetes uses an at home glucometer to test his blood sugar levels. | Image source: Getty Images

SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System

Senseonics announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.

Equity

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Analysts

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities...

Maven Securities LTD Takes Position in Senseonics Holdings, Inc. $SENS

Maven Securities LTD acquired a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Hood River Capital Management LLC Invests $3.78 Million in Senseonics Holdings, Inc. $SENS

Hood River Capital Management LLC acquired a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the second quarter, according to the company in its most recent...

Vistagen Appoints Nick Tressler as Chief Financial Officer

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product...

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$7.42
Prev Close	$6.91
Open	$7.01
Dividend Yield	0.00%
50-Day Moving Average	$6.68
Beta	1.74
Avg. Volume	438,567.25
PE Ratio	-4.35

52-Week High	$28.00
52-Week Low	$5.25
Market Capitalization	$303.58M
EPS (Annual)	-$2.50
Price to Book	3.88
Revenue Per Employee	$192,068.38
Enterprise Value/EBITDA	N/A

SENS
Senseonics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SENS News

SENSSenseonics Holdings Inc